5 Ergebnisse
BACKGROUND OF THE INVENTION
The present invention relates to a novel polysaccharide isolated from Panax ginseng having the hematopoietic, myeloprotecting, antitumor immune cells generating and radiosensitizing activities. The present invention also includes the preparation method of the
This application is the U.S. National Phase under 35 U.S.C. .sctn.371 of International Application PCT Patent Application No. PCT/KR2004/001941, filed on Aug. 2, 2004, which claims priority to Korean Patent Application No. 10-2004-055088, filed on Jul. 15, 2004, the contents of which are all herein
TECHNICAL FIELD
The present invention relates to a composition containing, as an effective ingredient, an extract from the leaves and/or stems of plants belonging to Panax genus and a process for preparation of the polysaccharides, and more particularly a composition containing polysaccharides
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a U.S. national phase of International Application No. PCT/KR2009/006523 filed on Nov. 6, 2009, which claims the benefit of Korean Application No. 10-2008-0110086 filed on Nov. 6, 2008, the contents of which are hereby incorporated by
TECHNOLOGICAL FIELD
The present invention concerns compositions having physiological activities, including but not limited to anti-tumor activity and hypoglycemic effects (i.e. blood sugar level reducing effects). More particularly, compositions are taught that comprise active ingredients found in